Additionally, changes in orexin signaling and glucose sensitivity might occur in endocrine disorders such as hypogonadism or polycystic ovarian syndrome (PCOS), which are often marked by altered sex steroid levels. This evidence concerns the gene HCRT and endocrine system disorder.